FDA Inspection
Dendreon Pharmaceuticals LLCFDA Inspection 1303248 - Dendreon Pharmaceuticals LLC - March 25, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on March 25, 2026, issued by the Los Angeles District Office, covering biologics.
Open in Dashboard
ID · 18d0f24c-cd63-43db-ac7c-9cb2177b0278
Violation Codes9
21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.115(b)21 CFR 211.188(b)21 CFR 211.19221 CFR 211.194(a)(8)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.94(a)
Full citation text and observation details available on the Dashboard.